Sampre Nutritions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the unaudited standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sampre Nutritions has informed BSE that its Board of Directors will meet on Friday, 13 February 2026. The key agenda item is to approve the unaudited standalone and consolidated financial results for the third quarter (October–December 2025) and the nine-month period ended 31 December 2025. The Board will also consider appointing a new non-executive non-independent additional director to the Board. The intimation has been filed under SEBI Listing Regulations and signed by Managing Director Brahma Gurbani.
This is a routine procedural filing ahead of the Q3 FY26 results announcement on 13 February. Investors should watch the actual results for earnings trends, while the new director appointment could signal board-level changes but carries no immediate financial impact on shareholders.